Skip to main content
Fig. 2 | Antimicrobial Resistance and Infection Control

Fig. 2

From: Antimicrobial susceptibility and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae from intensive care units at Hamad Medical Corporation, Qatar

Fig. 2

In vitro activity of the identification and antimicrobial susceptibility test panel of antimicrobial agents against clinical extended-spectrum beta-lactamase-producing isolates. The in vitro activity of antimicrobial agents against clinical isolates was analyzed by BD Phoenix. AK (amikacin), AMC (amoxicillin/clavulanic acid), PM (cefepime), FX (cefoxitin), CRO (ceftriaxone), CI (ciprofloxacin), ETR (ertapenem), GM (gentamicin), IP (imipenem), MP (meropenem), PTC (piperacillin/tazobactam), TGC (tigecycline), TS (trimethoprim/sulfamethoxazole)

Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us